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http:WHAT THIS PAPER ADDS
Remote ischemia conditioning is associated with angiogenic promotion in the ischemic tissue. This study pro-
vides preliminary data showing that repeated short ischemic stimuli may reduce critical ischemic injury by
promoting angiogenesis.Objectives: Ischemic conditioning (IC) is a method of angiogenic stimulus for limb ischemia. Here, we aimed to
investigate the effects of short-term repeated ischemic stimulus on critical lower limb ischemic injury.
Methods: Rats were divided into four groups consisting of 40 animals in each group: sham, ischemia, local IC, and
remote IC groups. Right-leg critical limb ischemia was achieved through ligation of the iliac artery and vein in
male SpragueeDawley rats except the sham group. Repeated transient ischemia using the tourniquet method
was used for IC of lower extremities in the local and remote groups. IC was performed on the right leg for the
local group and on the left leg for the remote group. Ten rats in each group were sacriﬁced for evaluation on days
1, 7, 14, and 30. Endothelial progenitor cell (EPC) counts were measured. Gastrocnemius muscles were evaluated
for the degree of ischemia. Laser Doppler blood ﬂow measurements were performed in order to make
comparison between the blood ﬂows of the limbs of the groups.
Results: The blood ﬂow in the right limb of rats in the sham (1.65 perfusion units [PU]) and local IC (1.67 PU)
groups was signiﬁcantly higher than the ischemic group (1.17 PU) (p ¼ .001 and p ¼ .022 respectively). The levels
of EPCs in the ischemia (1.09  0.5) and remote IC groups (1.36  0.8) were signiﬁcantly higher than the sham
(0.38  0.2) group on day 7 (p ¼ .026 and p ¼ .002 respectively). Remote IC and local IC groups exhibited
increased histopathological ischemia on day 7 when compared with sham group (p ¼ .001, p ¼ .01 respectively).
The angiogenic scores on the 7th, 14th and 30th days for local IC and remote IC groups were signiﬁcantly higher
than sham and ischemia groups.
Conclusions: IC seems to be the potent activator of angiogenesis in ischemic tissue. This study provides
preliminary data showing that repeated short ischemic stimuli may reduce critical ischemic injury by promoting
angiogenesis.
 2013 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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Standard treatments for critical limb ischemia are surgical
or endovascular revascularizations. When surgical or endo-
vascular treatment is not an option, the clinical manifesta-
tions of critical limb ischemia are dependent on the balance
between the rapidity and extent of “natural” collateral
vessel growth versus the progression of occlusive arterialresponding author. R. Karakoyun, SB Etlik _Ihtisas Hastanesi,
ment of General Surgery, Etlik, Ankara, Turkey.
il address: drrojbin@hotmail.com (R. Karakoyun).
-5884/$ e see front matter  2013 European Society for Vascular
. Published by Elsevier Ltd. All rights reserved.
//dx.doi.org/10.1016/j.ejvs.2013.11.001disease. On the other hand, direct revascularization may be
unsuccessful in some cases due to the anatomic extent and
distribution of arterial occlusive disease.1 The deﬁciency in
effective treatment options for non-reconstructable critical
limb ischemia has led to research on cellular therapy as an
alternative. As a result, alternative methods, such as gene
therapy, stem cell therapy, and angiogenic stimulators have
been investigated,2 and much of these have concentrated
on the concept of therapeutic angiogenesis.
The deﬁnition of “ischemic conditioning” (IC) is the
application of a series of alternating intervals of brief
ischemia and reperfusion in the setting of prolonged
ischemia causing tissue necrosis. The conditioning stimulus
can be applied before (ischemic preconditioning, IPC),
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major ischemic event. All three methods of conditioning are
associated with tissue protection not only in normal phys-
iology, but in both animal models and in humans with
ischemiaereperfusion syndromes. Several studies have
shown the beneﬁcial effects of preconditioning and post-
conditioning in different ischemiaereperfusion models.3,4
However, ischemia itself is a stimulus for angiogenesis.
Also, IC itself may be a stimulus for angiogenesis in the
ischemic tissue, and it has been shown that remote IPC
would lead to the activation of nerve pathways and the
release of biochemical messengers, including angiogenic
ones.5,6 More recently, in a liver ischemia model, it has
been reported that IC seems to be a potent activator of
angiogenic genes.7 Despite the substantial amount of
research on IC in acute ischemia models, the impact of IC on
critical ischemic injury has been less well studied.
Endotheliumwhich is in the quiescent state in the vascular
tree starts to proliferate in response to injury, growth factors,
or neovascularization. Sprouting of endothelium is driven by
the recruitment of circulating endothelial progenitor cells
(EPCs).8 The EPC population contained in the CD34/CD45 cell
fraction develops into endothelial colony-forming cells and
they display the characteristics of mature endothelial cells,
have a high proliferative capacity, and are able to form
capillary-like structures.9 EPCs lose typical progenitor
markers and acquire endothelial markers and two important
receptors (VEGF and CD34) which recruit circulating EPC to
damaged or ischemic microcirculation beds.10
Ischemic preconditioning might be a promising and
importantmethod in the treatment of critical limb ischemia by
increasing new vessel formation, and the creation of angio-
genic stimulators.We hypothesized that short-term repeated
ischemic stimulus could reduce critical ischemic injury
because of its angiogenic effect. To test this hypothesis, we
aimed to investigate the effects of short-term repeated
ischemic stimulus on critical ischemic injury of the remote
organbydetermining angiogenesiswithmeasurements of EPC
levels, by determining necrosis with histopathological analysis
and by measuring limb perfusion with laser Doppler imaging.
MATERIALS AND METHODS
Animal model
Male SpragueeDawley rats weighing 180e250 g were
housed under cycles of 12 h of light and 12 h of dark in
individual cages, and were allowed free access to standardFigure 1. Summary of the study protocol. R (right), L (left), IC (ischemic
arrows ischemic conditioning in every day for 1, 7, 14, and 30 days.rat chow and water. All experiments were performed with
rats that had fasted for 12 h before surgery. Animal housing,
care, and the application of experimental procedures were
all done in accordance with The Guidelines for Care and Use
of Laboratory Animals, published by the National society for
Medical Research and the National Institute of Health. All of
the animal experiments described herein were approved by
the Institutional Review Board.Critical limb ischemia model
The rats were divided into four groups consisting of 40
animals each: sham group, ischemia group, local IC group,
and remote IC group (Fig. 1). Right-leg critical limb
ischemia was created by iliac artery and vein ligation, as
described previously.11 Brieﬂy, the rats were anesthetized
with 100 mg/kg intraperitoneal (ip) ketamine (Ketalar,
Parke-Davis). A midline incision was made in the
abdomen, and the right common iliac artery and vein
were circumferentially exposed. The artery and vein were
doubly ligated with a 6/0 polyglactin suture (coated Vicryl
Ethicon, Somerville, NJ, USA) and divided proximal to the
internal iliac artery. During the procedure, to avoid in-
ﬂuences arising from major ﬂuid loss or drying of the liver,
the abdominal cavity was covered with wetting gauze.
Following ligation, the abdominal wall was closed with
interrupted sutures. After the creation of ischemia in the
right limb of rats, rats in the local and remote groups were
taken in order to perform conditioning stimulus. In pilot
studies, we tested the presence of ischemia in this model
using laser Doppler imaging. Also, in all experiments,
critical ischemia in the right limb was observed by visual
inspection.
ICs of either right (local) or left (remote) legs were ach-
ieved through repeated transient ischemia using the tour-
niquet method. Under anesthesia with low-dose ip
ketamine (30 mg/kg body weight), a tourniquet (MAS
rubber band, number 15) was looped six times as proximal
as possible to the thigh. Ten minutes of ischemia followed
by 10 minutes of reperfusion were performed three times
every morning for the assigned period of time. The time
period was similar to the study of Weinbrenner et al.12
Repeated transient ischemia performed after right limb
ischemia is a way of post-conditioning. Repeated transient
ischemia was performed after the initial rat pads were
scanned with a laser Doppler imager (Perimed PIM II, Jar-
walle, Sweden) for conﬁrmation of transient ischemia. Ratsconditioning), S (tissue sampling), L (laser imager evaluation), gray
Figure 2. Example from multicolor ﬂow cytometry phenotyping to demonstrate VEGF-2 and CD34. Gating strategies to detect endothelial
progenitor cells by whole blood ﬂow cytometry; one representative blot of endothelial progenitor cells is shown. (A) Forward/sideward
scatter with lymphocyte gate (R1) indicated. Acquisition was stopped after 100,000 events acquired in R1. (B) Double-positive cells for
CD34, VEGF-2, and CD34/VEGF-2 were determined and described as a percentage of the lymphocyte population (R 1).
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rotomy only. Rats in the ischemia group underwent per-
manent right limb ischemia only. Rats in the local IC group
were subjected to ipsilateral (right limb) repeated transient
ischemia after permanent right limb ischemia. Rats in the
remote IC group were subjected to contralateral (left limb)
repeated transient ischemia after permanent right limb
ischemia. Transient ischemia was applied to the rats in the
local and remote groups for different time periods: 1, 7, 14,
and 30 days. There were 10 rats in each time period study.
After 1-, 7-, 14-, and 30-day transient ischemia periods, 10
rats from each group were killed for evaluation. To exclude
the effects of anesthesia that had been given every day to
the transient ischemia groups, the same dose of anesthesia
was also given to the sham and ischemia groups during the
experiment. In order to make the method more under-
standable, we added a ﬂow chart (Fig. 1). At the end of the
time periods, blood samples were taken from the abdom-
inal aorta for EPC count evaluations. Tissue samples were
taken from the gastrocnemius muscle of the critical (right)
ischemic limb for the evaluation of the degree of ischemia.
Laser Doppler blood ﬂow measurement was performed on
day 30 of the experiment. The laser Doppler results of the
sham group were regarded as the basal level.Endothelial progenitor cells
Endothelial progenitor cells (EPCs) were measured by the
method described by Goldstein et al.13 EPCs have mem-
brane markers for vascular endothelial growth factor-2
(VEGF-2), CD34, CD117, CD133, CD31, VE-cadherin, and
vWf. In this method, multicolor ﬂow cytometry phenotyping
was used to demonstrate VEGF-2 and CD34 (Fig. 2). The test
depends on the binding of speciﬁc monoclonal antibodies,
expressed by the leucocytes, to the antigenic markers. In
selected cells, analysis was performed based on the differ-
entiation of ﬂuorescent-positive cells (binding to anti-mouse CD34 and VEGF-2 without cross-reaction) as
mentioned in a previous study.14
Flow measurement
Limb perfusion was assessed on day 30 using laser Doppler
perfusion imaging, and was quantiﬁed using the laser
Doppler imager (Fig. 3). Laser Doppler perfusion imaging
was performed in a temperature-controlled (28e30 C)
facility with weight-based sedation, and in a dark room to
minimize artifacts due to temperature ﬂuctuations and
levels of sedation. The limb was deﬁned as all-imaged tissue
distal to the inguinal ligament of the rat in prone position
and the foot sole in supine position. Signals from the skin
were recorded continuously for 4 minutes by ﬁberoptic
probe. The results were given in PU (perfusion units).
Evaluation of angiogenesis
In the tissue samples, immunohistopathologic examinations
for angiogenesis were performed using CD34 tissue anti-
bodies. CD34 is an important target for therapeutic angio-
genesis as reported in several studies.15e17 Cytoplasmic
CD34 staining was accepted as positive for angiogenesis, in
accordance with the previous studies.15e17,19
Determination of muscle necrosis
The tissue samples from gastrocnemius muscle were kept in
10% formaldehyde. Hematoxylin and eosin microscopic
evaluation of ischemia was performed according to the
criteria mentioned in the study by Carter et al.18 A sub-
jective histopathology score was recorded for each muscle
group and ranged from 0 to 10: 0 ¼ no abnormal score;
1 ¼ mild localized mononuclear cell inﬁltration;
3 ¼ moderate generalized mononuclear cell inﬁltration,
occasional necrotic ﬁbers; 10 ¼ massive cell inﬁltration, and
complete loss of tissue architecture. A mean muscle histo-
pathology score (MHS) was recorded as the mean

























α  p=0.001,  β p=0.02,  # p=0.04, µ p=0.35 
Figure 4. Comparison of the blood ﬂow rates in the right limbs of
the rats on the 30th day.
Figure 3. Examples of laser Doppler images of the rats. The decreased blood ﬂow in the right limb as a result of critical limb ischemia is
shown (dorsal view). (A) Laser Doppler image of a rat in õschemia group. Decreased blood ﬂow in right limb is shown. (B) Laser Doppler
image of a rat in the local ischemic conditioning group. Decreased blood ﬂow in right limb is shown.
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animals. The pathological evaluation was performed by an
experienced pathologist who had no idea or information
about the groups.
Statistical analyses
Data which were normally distributed are presented as
mean  SEM. A computer program (SPSS version 13.00;
SPSS Inc. Chicago, IL, USA) was used for statistical analysis.
The difference between EPC levels and the number of CD34
stained cells on each day among groups and blood ﬂows
was determined by one-way analysis of variance (ANOVA)
followed by a post hoc Tukey test. The median MHC results
were given among groups because of the non-
homogeneous distribution of the results (p < .05, Kolmo-
goroveSmirnov test). Non-parametric statistical evaluation
of MHS was performed by the KruskaleWallis test. A p
value < .05 was considered statistically signiﬁcant.
RESULTS
No mortality was observed during the experiment. The re-
sults of blood ﬂow obtained from laser Doppler on day 30
are given in Fig. 4. Also, an example of laser Doppler images
of the rats is provided in Fig. 3. There was a signiﬁcant
difference between groups (p ¼ .001, ANOVA). It can be
seen that the blood ﬂows of the right limb of rats in the
sham (1.65  0.28) and local IC (1.67  0.4) groups were
signiﬁcantly higher than that of the ischemic group
(1.17  0.14) (p ¼ .001 and p ¼ .022, respectively).
Although a signiﬁcant difference was noted between
remote IC (1.28  0.1) and sham groups (p ¼ .04), the same
could not be observed between local IC and remote IC
groups (p ¼ .35). There was no signiﬁcant difference be-
tween the ﬂow rate of left limb of the groups (p > .05).
The levels of circulating EPCs are given in Fig. 5, and an
example from multicolor ﬂow cytometry phenotyping to
demonstrate VEGF-2 and CD34 of the rats can be seen in
Fig. 2. There was no difference in the levels of EPCs among
the groups on the ﬁrst day of the experiment (p ¼ .87,
ANOVA). However, signiﬁcant changes were observed on
day 7 (p ¼ .001, ANOVA); the levels of EPC in ischemia
group on day 7 were signiﬁcantly higher than that of the
sham group on day 7 (p ¼ .026). The levels of EPCs inremote IC groups on day 7 were signiﬁcantly higher than
that of the sham group on day 7 (p ¼ .002). Furthermore,
the levels of EPCs in the remote IC group were signiﬁcantly
higher than that of the local IC group (p ¼ .013).
There were no signiﬁcant differences in the MHS for the
gastrocnemius muscle among the time points in the sham
group. Ischemia was observed in the study groups. There
were signiﬁcant differences between groups on days 7 and
30. Remote IC and local IC groups exhibited increasedMHS on
day 7 when compared with that of the sham group (p ¼ .01
and p ¼ .02 respectively). There was a signiﬁcant difference
between theMHS levels of ischemia and remote IC groups on
day 7 (p¼ .01). MHS on day 30 was signiﬁcantly increased in
the ischemia group when compared with that in the sham
group (p ¼ .04). MHS of the local IC group was signiﬁcantly
increased on day 30 when compared with that of the sham
group (p ¼ .01). There was a signiﬁcant increase in MHS
scores in the local IC group when compared with the remote
IC group on day 30 (p ¼ .02). Furthermore, there were sig-
niﬁcant differences between the MHC levels of local IC and
ischemia groups on day 30 (p ¼ .04) (Table 1).
The comparison of angiogenic scores is given in Fig. 6. On
day 1, there were no signiﬁcant differences between the
angiogenesis scores of the groups (p ¼ .98, ANOVA). On























Figure 5. The mean EPC levels of groups within days.
176 R. Karakoyun et al.days 7, 14, and 30, there were signiﬁcant differences be-
tween groups (p ¼ .001, ANOVA). Local IC and remote IC
groups had signiﬁcantly increased angiogenesis when
compared with the sham group (p < .001). The remote IC
group had signiﬁcantly increased angiogenesis compared
with the ischemia group on day 7 (p < .001). On day 14,
angiogenesis in the sham group was signiﬁcantly lower than
in the local IC and remote IC groups (p < .001). Angio-
genesis in the ischemia group was signiﬁcantly lower than
in the local IC and remote IC groups (p ¼ .007 and p < .001,
respectively). On day 30, angiogenesis in the sham group
was signiﬁcantly lower than the ischemia, local IC and
remote IC groups (p ¼ .041, p < .001, p < .001 respec-
tively). Angiogenesis in the ischemia group was signiﬁcantly
lower than in the local IC and remote IC groups (p < .001).DISCUSSION
Several studies have shown the beneﬁcial effects of pre-
conditioning and post-conditioning in different ischemiae
reperfusion models.3,5,6,20e28 IC already has clinicalTable 1. The mean muscle histopathology scores for the
gastrocnemius muscle of the right limb of rats of all groups are
given by p values.
Group Days
Day 1 Day 7 Day 14 Day 30
Sham 0 (0e2) 0 (0) 0.5 (0e3) 1 (0e1)
Ischemia 0 (0e1) 0 (0e3) 2 (1e3) 1.5 (0e3)
Local IC 0 (0e1) 1 (0e4) 2 (1e3) 2.5 (1e5)
Remote
IC
0 (0e1) 1.5 (0e4) 1 (0e3) 1 (0e2)
p Values Sham vs.
local
IC, p ¼ .02
Sham vs.
remote
IC, p ¼ .01
Ischemia vs.
remote





IC, p ¼ .01
Ischemia vs. local
IC, p ¼ .04
Local IC vs.
remote IC,
p ¼ .02applications in acute events such as myocardial ischemia and
cardiac surgery. The discovery that remote IC can be per-
formed non-invasively using a blood pressure cuff on the
upper arm to induce brief episodes of limb ischemia and
reperfusion has facilitated the translation of IC into the clin-
ical arena.29,30 In this study, we tried to investigate the effects
of intermittent ischemia on established limb ischemia. For
this purpose, we investigated the effects of both local (in situ)
and remote repeated intermittent limb ischemia on critical
limb ischemia. The most important physiological and
morphological ﬁnding of the present study is that local and
remote ischemic stimuli might signiﬁcantly increase the
blood ﬂow and capillary supply in the ischemic limb. This
ﬁnding has not been previously reported.
The formation of true new blood vessels, or angiogenesis,
and the development of collateral vessels from pre-existing
blood vessels, or arteriogenesis, are important in the
pathophysiology of vascular disease. Hypoxia or ischemia
itself is one of the stronger inducers of angiogenesis. By
stimulating these processes, it may be possible to provide
an alternative treatment strategy for patients with non-
reconstructable lower limb ischemia. Research in thera-
peutic angiogenesis to treat ischemia has been performed
for decades. Arteriogenesis, when the lumen of pre-existing
vessels increases to form collateral arteries, is a process that
can ameliorate the harmful effects of vessel obstruction.
Remote IC is a physiological adaptation mechanism,
whereby brief exposure to non-lethal ischemia in one tissue
confers protection against a prolonged ischemic insult in a
distant tissue.22,23 Several clinical trials about cardiac
ischemia have reported the beneﬁcial effects of remote IC
in different clinical settings.20,24 Also, contralateral hind
limb remote IPC prior to ipsilateral cremasteric ﬂap
ischemia and reperfusion in a rat model has been observed
to improve red blood cell ﬂow and reduce neutrophil
adhesion.21,25,27 Liauw et al.28 showed that remote IPC
(ipsilateral gracilis) reduced muscle necrosis of contralateral
muscles by 60%, when compared with non-preconditioned
controls. These studies show that remote IPC is associated
with better microcirculation, decreased leucocyte endo-
thelial sticking and endothelial dysfunction, as well as better
capillary blood ﬂow with terminal arteriole dilation.25
However, the above-mentioned studies have been per-
formed in acute ischemiaereperfusion injury settings. To
our knowledge, the present study is the ﬁrst to investigate
both in situ and remote repeated intermittent limb
ischemia in critical limb ischemia.
In the current study, we found that remote IC caused
increased angiogenesis in the ischemic tissue. Despite the
higher angiogenic scores with remote IC, these ﬁndings
were not associated with amelioration in tissue injury and
blood ﬂow in the critical ischemic limb. On the other hand,
local IC in the critical ischemic limb was associated with
increased angiogenesis, as well as improved blood ﬂow.
However, tissue injury was even higher in this group than
that in the ischemic group. It was thought that the blood
ﬂow rate in the local IC group was increased because of the
inﬂammation occurring in the ipsilateral limb because of
Figure 6. Comparison of angiogenesis between groups. The differences between groups are shown in the ﬁgure. *p < .001.
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the increased ischemia score is probably due to the
repeated ischemic trauma in the ipsilateral limb. The higher
tissue injury seen in the local IC group may be related to the
technique of conditioning.We used IC by wrapping a rubber
band under light anesthesia, which can itself cause damage.
Local IC is associated with higher ﬂow and MHC value in the
ischemic limb. We believe that local IC may cause better
conditioning but less tissue protection because of de novo
tissue damage in the already injured tissue.
In the experiment, limb perfusionwas assessed only on day
30 by using laser Doppler perfusion imaging. Unfortunately,
we did not perform laser measurements for all time points,
namely day 1, day 7, and day 14, and we did not induce
ischemia. There was no difference in the ﬂow of the left leg
which was used for control or conditioning on day 30. How-
ever, blood ﬂow diminished in the ischemic right leg in ani-
mals in the ischemia group. Local IC resulted in an increase in
blood ﬂow in the ischemic right leg, but remote IC did not
result in increased ﬂow in the ischemic right leg. Amelioration
of tissue injury in the remote IC group without any increase in
blood ﬂow may be related to other mechanisms of IC.
The results of the present study suggest that IC promotes
angiogenesis. Although the actual angiogenic mechanistic
pathway underlying IC remains to be elucidated, it might be
related to the cascade following ischemic insult. Induction
of ischemia has previously been shown to occur in animal
models of skeletal muscle ischemia and systemic hypoxia.31
Transient õschemia promotes arteriogenesis, inﬂammation,
and EPC recruitment.11,13,31e34 In response to ischemic in-
sults, most of the tissues in the body have extraordinary
capacities to compensate for low levels of oxygen by
mechanisms of vasodilation, angiogenesis, arteriogenesis,
vascular remodeling, and hematopoiesis.23,34 Molecular
mechanisms underlying the compensation of oxygen
involve induction of a distinct set of gene products that
control the transcriptional activation of vascular and he-
matopoietic modulators.7,35,36 Also, the inﬁltratinginﬂammatory cells or, potentially, EPCs that invade in
response to acute ischemia may assist in arteriogenesis and
blood ﬂow recovery in animal models that rely on ligation
or excision.31 In this study, we used IC for 1, 7, 14, and 30
days after right-leg ischemia in relation to EPCs.
This study has important limitations. First, we used IC by
wrapping a rubber band under light anesthesia, which can
itself cause damage. The higher tissue injury seen in the
local IC group may be related to the technique of condi-
tioning. The second limitation is the aim to investigate the
level of angiogenesis, and not arteriogenesis, in the
ischemic limb. Arteriogenesis to increase blood ﬂow, is
distinct from microvascular angiogenesis. The clinical
observation of robust collateral formation allowing asymp-
tomatic limb perfusion and function in many patients con-
ﬁrms the importance of arteriogenesis as a necessary
component of revascularization. Therefore, angiogenesis
itself may not be good enough for critically ischemic limbs.
The absence of amelioration in tissue injury in local and
remote IC groups may be related to insufﬁciency of arte-
riogenesis, instead of angiogenesis. Finally, we did not
measure the functional outcome of ischemic legs in the
animals, which is an index of arteriogenesis.
In summary, we have found that remote IC is associated
with angiogenic promotion in ischemic tissue. This study
provides preliminary data showing that repeated short
ischemic stimuli may reduce critical ischemic injury by
promoting angiogenesis. Our model can be used in cases in
which reconstruction was not possible. However, further
studies are required to establish the protective effects and
the mechanism of angiogenesis promoted by IC.FUNDING
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